Abstract
A scalable two-pot sulfonamidation through the process has been developed for the synthesis of gefapixant citrate, a P2X3 receptor antagonist that is under investigation for the treatment of refrac...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have